{"id":170,"date":"2005-04-18T08:16:03","date_gmt":"2005-04-18T08:16:03","guid":{"rendered":"https:\/\/palladiumcapital.com\/wp-padium\/?p=170"},"modified":"2013-08-04T01:35:20","modified_gmt":"2013-08-04T01:35:20","slug":"palladium-capital-advisors-acts-as-co-placement-agent-on-protein-polymer-technologies-7-75-million-private-placement","status":"publish","type":"post","link":"https:\/\/www.palladiumcapital.com\/palladium-capital-advisors-acts-as-co-placement-agent-on-protein-polymer-technologies-7-75-million-private-placement\/","title":{"rendered":"Palladium Capital Advisors Acts as Co-Placement Agent on Protein Polymer Technologies&#8221; $7.75 Million Private Placement"},"content":{"rendered":"<p><a href=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/tomb_protein.jpg\"><img decoding=\"async\" loading=\"lazy\" class=\" wp-image-427 alignleft\" alt=\"tomb_protein\" src=\"https:\/\/palladiumcapital.com\/wp-content\/uploads\/2013\/07\/tomb_protein-260x300.jpg\" width=\"156\" height=\"180\" srcset=\"https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/tomb_protein-260x300.jpg 260w, https:\/\/www.palladiumcapital.com\/wp-content\/uploads\/2013\/07\/tomb_protein.jpg 546w\" sizes=\"(max-width: 156px) 100vw, 156px\" \/><\/a>April 18, 2005: Protein Polymer Technologies (OTCBB:PPTI) announced today the final closing of a private placement of common stock and warrants yielding total gross proceeds of approximately $7.75 million in which Palladium Capital Advisors acted as co-placement agent. Protein Polymer Technologies is a company focused on high performance bioactive devices designed for improved surgical outcomes. The net proceeds will be used to fund Protein Polymer&#8217;s research and clinical programs, and for general corporate purposes, including potential acquisitions. Investors in the private placement included both institutional and individual accredited investors.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.prnewswire.com\/cgi-bin\/stories.pl?ACCT=104&amp;STORY=\/www\/story\/04-18-2005\/0003432748&amp;EDATE=\" target=\"_blank\">See full press release&#8230;<\/a><br \/>\n<a title=\"Protein Polymer Technologies, Inc.\" href=\"https:\/\/palladiumcapital.com\/protein-polymer-technologies-inc\/\" target=\"_blank\">For More information on Protein Polymer Technologies&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>April 18, 2005: Protein Polymer Technologies (OTCBB:PPTI) announced today the final closing of a private placement of common stock and warrants yielding total gross proceeds of approximately $7.75 million in which Palladium Capital Advisors acted as co-placement agent. Protein Polymer Technologies is a company focused on high performance bioactive devices designed for improved surgical outcomes. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"_links":{"self":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/170"}],"collection":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/comments?post=170"}],"version-history":[{"count":0,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/posts\/170\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/media?parent=170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/categories?post=170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.palladiumcapital.com\/wp-json\/wp\/v2\/tags?post=170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}